These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 11187394)

  • 21. Apolipoprotein E prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
    Yamada N; Inoue I; Kawamura M; Harada K; Watanabe Y; Shimano H; Gotoda T; Shimada M; Kohzaki K; Tsukada T
    J Clin Invest; 1992 Feb; 89(2):706-11. PubMed ID: 1737858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].
    Li Z; Yang YJ; Qin XW; Ruan YM; Chen X; Meng L; Zhang HD
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3146-50. PubMed ID: 17313769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antioxidants suppress plasma levels of lectinlike oxidized low-density lipoprotein receptor-ligands and reduce atherosclerosis in watanabe heritable hyperlipidemic rabbits.
    Oka K; Yasuhara M; Suzumura K; Tanaka K; Sawamura T
    J Cardiovasc Pharmacol; 2006 Oct; 48(4):177-83. PubMed ID: 17086097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural history of atherosclerosis and hyperlipidemia in heterozygous WHHL (WHHL-Hh) rabbits. I. The effects of aging and gender on plasma lipids and lipoproteins.
    Esper E; Chan EK; Buchwald H
    J Lab Clin Med; 1993 Jan; 121(1):97-102. PubMed ID: 8426086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined effects of an 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor and angiotensin II receptor antagonist on nitric oxide bioavailability and atherosclerotic change in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits.
    Imanishi T; Ikejima H; Tsujioka H; Kuroi A; Kobayashi K; Shiomi M; Muragaki Y; Mochizuki S; Goto M; Yoshida K; Akasaka T
    Hypertens Res; 2008 Jun; 31(6):1199-208. PubMed ID: 18716369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural history of atherosclerosis and hyperlipidemia in heterozygous WHHL (WHHL-Hh) rabbits. II. Morphologic evaluation of spontaneously occurring aortic and coronary lesions.
    Esper E; Runge WJ; Gunther R; Buchwald H
    J Lab Clin Med; 1993 Jan; 121(1):103-10. PubMed ID: 8426070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
    Mulvihill EE; Assini JM; Sutherland BG; DiMattia AS; Khami M; Koppes JB; Sawyez CG; Whitman SC; Huff MW
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):742-8. PubMed ID: 20110573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
    Millar JS; Brousseau ME; Diffenderfer MR; Barrett PH; Welty FK; Faruqi A; Wolfe ML; Nartsupha C; Digenio AG; Mancuso JP; Dolnikowski GG; Schaefer EJ; Rader DJ
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1350-6. PubMed ID: 16574893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of long-term treatment with sulfatide on hyperlipidemia and progression of atherosclerosis in WHHL rabbits.
    Taketomi T; Hara A; Uemura K; Kyogashima N
    Jpn J Exp Med; 1989 Dec; 59(6):221-31. PubMed ID: 2622064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of pravastatin on cholesterol metabolism of cholesterol-fed heterozygous WHHL rabbits.
    Harsch M; Gebhardt A; Reymann A; Lang G; Schliack M; Löser R; Braesen JH; Niendorf A
    Br J Pharmacol; 1998 May; 124(2):277-82. PubMed ID: 9641543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nifedipine suppressed atherosclerosis in cholesterol-fed rabbits but not in Watanabe heritable hyperlipidemic rabbits.
    Watanabe N; Ishikawa Y; Okamoto R; Watanabe Y; Fukuzaki H
    Artery; 1987; 14(5):283-94. PubMed ID: 3662844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits.
    Shiomi M; Ito T; Tsukada T; Yata T; Watanabe Y; Tsujita Y; Fukami M; Fukushige J; Hosokawa T; Tamura A
    Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1938-44. PubMed ID: 7583574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose cerivastatin inhibits spontaneous atherogenesis in heterozygous watanabe hyper lipidemic rabbits.
    Pauletto P; Puato M; Faggin E; Sartore S
    J Vasc Res; 2000; 37(3):189-94. PubMed ID: 10859477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-very low density lipoprotein uptake in cultured fibroblasts and smooth muscle cells from Watanabe heritable hyperlipidemic rabbits.
    Wernette-Hammond ME; Garcia Z; Arnold KS; Innerarity TL
    Arteriosclerosis; 1989; 9(4):501-10. PubMed ID: 2546526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of NO-1886, a lipoprotein lipase promoting agent, on homozygous and heterozygous Watanabe heritable hyperlipidaemic rabbits.
    Tsutsumi K; Inoue Y; Murase T
    Arzneimittelforschung; 2000 Feb; 50(2):118-21. PubMed ID: 10719613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a novel antihyperlipidemic agent, S-2E, on the blood lipid abnormalities in homozygous WHHL rabbits.
    Ohmori K; Yamada H; Yasuda A; Yamamoto A; Matsuura N; Kiniwa M
    Metabolism; 2004 May; 53(5):680-5. PubMed ID: 15131777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid-lowering effects of TAK-475, a squalene synthase inhibitor, in animal models of familial hypercholesterolemia.
    Amano Y; Nishimoto T; Tozawa Ri; Ishikawa E; Imura Y; Sugiyama Y
    Eur J Pharmacol; 2003 Apr; 466(1-2):155-61. PubMed ID: 12679152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pravastatin sodium, an inhibitor of HMG-CoA reductase, decreases HDL cholesterol by transfer of cholesteryl ester from HDL to VLDL in Japanese white rabbits.
    Miyazaki A; Koieyama T; Shimada Y; Kikuchi T; Ito K; Kasanuki N; Koga T
    J Atheroscler Thromb; 2004; 11(1):22-8. PubMed ID: 15067195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NK-104, a newly developed HMG-CoA reductase inhibitor, suppresses neointimal thickening by inhibiting smooth muscle cell growth and fibronectin production in balloon-injured rabbit carotid artery.
    Kitahara M; Kanaki T; Toyoda K; Miyakoshi C; Tanaka S; Tamaki T; Saito Y
    Jpn J Pharmacol; 1998 Jun; 77(2):117-28. PubMed ID: 9681568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HOE 402 lowers serum cholesterol levels by reducing VLDL-lipid production, and not by induction of the LDL receptor, and reduces atherosclerosis in wild-type and LDL receptor-deficient mice.
    Draijer R; Volger OL; Dahlmans VE; de Wit EC; Havekes LM; Princen HM
    Biochem Pharmacol; 2002 May; 63(9):1755-61. PubMed ID: 12007578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.